Background
The prevalence of morbid obesity (body mass index [BMI] ≥40 kg/m2 in women aged 20–39 years was 7.5% in 2009–2010. Morbid obesity is associated with an increased risk of stillbirth compared with normal BMI, especially after 39 weeks' gestation. The data regarding an increased risk of cesarean delivery associated with non-medically indicated induction of labor compared to expectant management in morbidly obese women are limited.
Objective
To compare the cesarean delivery rate of non-medically indicated induction of labor with expectant management in morbidly obese women without other comorbidity.
Study design
This was a retrospective cohort study from the Consortium on Safe Labor of morbidly obese women with singleton, cephalic gestations without previous cesarean, chronic hypertension, gestational and pregestational diabetes between 37 0/7 and 41 6/7 weeks' gestation. We examined maternal outcomes including cesarean delivery, operative delivery, third or fourth degree laceration, postpartum hemorrhage, and composite maternal outcome (any of transfusion, intensive care unit admission, venous thromboembolism). We also examined neonatal outcomes including shoulder dystocia, macrosomia (>4000 g), neonatal intensive care unit (NICU) admission, and composite neonatal outcome (5-min Apgar score <5, stillbirth, neonatal death, or asphyxia or hypoxic–ischemic encephalopathy). Adjusted odds ratios (aOR) with 95% confidence intervals (95%CI) were calculated, controlling for maternal characteristics, hospital type, and simplified Bishop score. Analyses were conducted at early and full term (37 0/7-38 6/7 and 39 0/7-40 6/7 weeks' gestation, respectively). Women who delivered between 41 0/7 and 41 6/7 weeks' gestation were included as expectant management group.
Results
Of 1,894 nulliparous and 2,455 multiparous morbidly obese women, 429 (22.7%) and 791 (32.2%) had non-medically indicated induction, respectively. In nulliparas, non-medically indicated induction was not associated with increased risks of cesarean delivery and was associated with decreased risks of macrosomia (2.2% vs. 11.0%; aOR=0.24; 95%CI=0.05-0.70) at early term and decreased NICU admission (5.1% vs. 8.9%; aOR=0.59; 95%CI=0.33-0.98) at full term compared with expectant management. In multiparas, non-medically indicated induction compared with expectant management was associated with a decreased risk of macrosomia at early term (4.2% vs. 14.3%; aOR=0.30; 95%CI=0.13-0.60), cesarean delivery at full term (5.4% vs. 7.9%; aOR=0.64; 95%CI=0.41-0.98), and composite neonatal outcome (0% vs. 0.6%; aOR=0.10; 95%CI=<.01-0.89) at full term.
Conclusion
In morbidly obese women without other comorbidity, non-medically indicated induction was not associated with an increased risk of cesarean delivery.